Literature DB >> 11965333

Free choice of sickness funds in regulated competition: evidence from Germany and The Netherlands.

Stefan Gress1, Peter Groenewegen, Jan Kerssens, Bernard Braun, Juergen Wasem.   

Abstract

Sickness funds became the focal point of health insurance reforms in the 1990s. Policy makers expected funds to become more consumer-oriented and more active in managing the provision of health care. This is especially true for two countries in the heart of Europe that, on first view, have many similar institutional characteristics. Both Germany and The Netherlands have introduced competition between sickness funds in the last decade. We present extensive quantitative, as well qualitative, data with regard to the behaviour of consumers after the introduction of free choice between sickness funds. National data was used with regard to contribution rates and member flows and survey data was used to investigate personal motives for actual change and perception of differences between sickness funds. In Germany, contribution rates between sickness funds differ significantly. Accordingly, these differences are the main reason for consumers to switch funds, which occurs on a considerable scale. However, survey data show that other reasons may be important too. In The Netherlands, premium differences are much lower. The same is true for the degree of change. Survey data show that consumers perceive very small differences between sickness funds and do not see much reason for change. Our findings support the claim that the degree of actual changing depends strongly on economic incentives, especially with regard to the extent of financial risk sickness funds have to bear and to the extent premiums or contribution rates can differ. However, the higher the financial risk of individual sickness funds actually is, the higher the incentives for risk selection.

Mesh:

Year:  2002        PMID: 11965333     DOI: 10.1016/s0168-8510(01)00193-2

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  8 in total

1.  Consumer price sensitivity and social health insurer choice in Germany and The Netherlands.

Authors:  Frederik T Schut; Stefan Gress; Juergen Wasem
Journal:  Int J Health Care Finance Econ       Date:  2003-06

2.  Consumer choice of social health insurance in managed competition.

Authors:  Jan J Kerssens; Peter P Groenewegen
Journal:  Health Expect       Date:  2003-12       Impact factor: 3.377

3.  Switching insurer in the Irish voluntary health insurance market: determinants, incentives, and risk equalization.

Authors:  Conor Keegan; Conor Teljeur; Brian Turner; Steve Thomas
Journal:  Eur J Health Econ       Date:  2015-09-10

4.  Measuring customer preferences in the German statutory health insurance.

Authors:  Jonas B Pendzialek; Dusan Simic; Stephanie Stock
Journal:  Eur J Health Econ       Date:  2016-09-21

5.  The intention to switch health insurer and actual switching behaviour: are there differences between groups of people?

Authors:  Michelle Hendriks; Judith D de Jong; Atie van den Brink-Muinen; Peter P Groenewegen
Journal:  Health Expect       Date:  2009-11-10       Impact factor: 3.377

6.  Regulated competition in health care: switching and barriers to switching in the Dutch health insurance system.

Authors:  Margreet Reitsma-van Rooijen; Judith D de Jong; Mieke Rijken
Journal:  BMC Health Serv Res       Date:  2011-05-10       Impact factor: 2.655

Review 7.  The experiences of merging health insurance funds in South Korea, Turkey, Thailand, and Indonesia: a cross-country comparative study.

Authors:  Mohammad Bazyar; Vahid Yazdi-Feyzabadi; Arash Rashidian; Anahita Behzadi
Journal:  Int J Equity Health       Date:  2021-02-26

8.  The Dutch health insurance reform: switching between insurers, a comparison between the general population and the chronically ill and disabled.

Authors:  Judith D de Jong; Atie van den Brink-Muinen; Peter P Groenewegen
Journal:  BMC Health Serv Res       Date:  2008-03-19       Impact factor: 2.655

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.